Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 26 Oct 2017
At a glance
- Drugs Nitric oxide (Primary)
- Indications Bronchiolitis
- Focus Registrational; Therapeutic Use
- Acronyms NO-BRO
- Sponsors AIT
- 17 Oct 2017 Planned End Date changed from 19 Aug 2017 to 19 Jun 2018.
- 17 Oct 2017 Planned primary completion date changed from 19 Aug 2017 to 19 Apr 2018.
- 17 Oct 2017 Status changed from recruiting to active, no longer recruiting.